Bausch + Lomb (NYSE:BLCO) received US FDA clearance for its Bi-Blade+ dual-port vitrectomy cutter and Adaptive Fluidics update, expanding its retina surgery toolkit. The company launched the enVista ...

Discover Avala Hospital's first-ever FDA-approved cataract lens for improved vision and quality of life in Covington, La.

Johnson & Johnson will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of Cataract and ...

RxSight continues to expand access to the Light Adjustable Lens through its growing network of trained surgeons and certified practices across the United States and select international markets. The ...

Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and ...

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

DALLAS, TX - LaserCare Eye Center, a leader in advanced vision correction, is proud to announce that its Office-Based ...

Chang described how the ASCRS Functional Vision Working Group is proposing a structured framework centered on visual quality, ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...

Complex cataract surgery presents unique challenges when capsular support is absent or compromised by trauma, ...

In our practice, corneal transplantation for keratoconus, whether that is penetrating keratoplasty or deep anterior lamellar ...